Hervé Le Breton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hervé Le Breton has a total of 152 co-authors. Here are the top co-authors by number of shared publications:
- Dominique Boulmier
Cardiologie, CHU de Rennes, F-35033 Rennes, Rennes, France
9 shared publications - Guillaume Leurent
Rennes University Hospital, Cardiology Department, INSERM, LTSI-UMR 1099, Rennes University , 2 rue Henri le Guilloux, 35000 Rennes
6 shared publications - Vincent Auffret
Department of Cardiology, Univ Rennes 1, Centre hospitalo-universitaire Rennes, Inserm, Laboratoire Traitement du Signal et de l’Image - Unité mixte de recherche n° 1099, France (V.A.).
6 shared publications Isabelle Coudert
5 shared publications- Marc Bedossa
Service de Cardiologie et maladies cardiovasculaires, Hôpital Pontchaillou, CHU Rennes, 2 rue Henri Le Guilloux, 35033 Rennes Cedex, France
5 shared publications Martine Gilard
5 shared publications
Latest Publications
- Open Access
- 22 July 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (15) , 3221
High Post-Procedural Transvalvular Gradient or Delayed Mean Gradient Increase after Transcatheter Aortic Valve Implantation: Incidence, Prognosis and Associated Variables. The FRANCE-2 Registry
Mean Gradient (MG) elevation can be detected immediately after transcatheter aortic valve implantation (TAVI) or secondarily during follow-up. Comparisons and interactions between these two parameters and their impact on outcomes have not previously been investigated. This study aimed to identify incidence, influence on prognosis, and parameters associated with immediate high post-procedural mean transvalvular gradient (PPMG) and delayed mean gradient increase (6 to 12 months after TAVI, DMGI) in the FRANCE 2 (French Aortic National CoreValve and Edwards 2) registry. The registry includes all consecutive symptomatic patients with severe aortic stenosis who have undergone TAVI. Three groups were analyzed: (1) PPMG < 20 mmHg without DMGI > 10 mmHg (control); (2) PPMG < 20 mmHg with DMGI > 10 mmHg (Group 1); and (3) PPMG ≥ 20 mmHg (Group 2). From January 2010 to January 2012, 4201 consecutive patients were prospectively enrolled in the registry. Controls comprised 2078 patients. In Group 1(n = 131 patients), DMGI exceeded 10 mmHg in 5.6%, and was not associated with greater 4-years mortality than in controls (32.6% vs. 40.1%, p = 0.27). In Group 2 (n = 144 patients), PPMG was at least 20 mmHg in 6.1% and was associated with higher 4-year mortality (48.7% versus 40.1%, p = 0.005). A total of two-thirds of the patients with PPMG ≥ 20 mmHg had MG < 20 mmHg at 1 year, with mortality similar to the controls (39.2% vs. 40.1%, p = 0.73). Patients with PPMG > 20 mmHg 1 year post-TAVI had higher 4-years mortality than the general population of the registry, unlike patients with MG normalization.
- 22 July 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (15) , 3221
Open AccessHigh Post-Procedural Transvalvular Gradient or Delayed Mean Gradient Increase after Transcatheter Aortic Valve Implantation: Incidence, Prognosis and Associated Variables. The FRANCE-2 Registry
Mean Gradient (MG) elevation can be detected immediately after transcatheter aortic valve implantation (TAVI) or secondarily during follow-up. Comparisons and interactions between these two parameters and their impact on outcomes have not previously been investigated. This study aimed to identify incidence, influence on prognosis, and parameters associated with immediate high post-procedural mean transvalvular gradient (PPMG) and delayed mean gradient increase (6 to 12 months after TAVI, DMGI) in the FRANCE 2 (French Aortic National CoreValve and Edwards 2) registry. The registry includes all consecutive symptomatic patients with severe aortic stenosis who have undergone TAVI. Three groups were analyzed: (1) PPMG < 20 mmHg without DMGI > 10 mmHg (control); (2) PPMG < 20 mmHg with DMGI > 10 mmHg (Group 1); and (3) PPMG ≥ 20 mmHg (Group 2). From January 2010 to January 2012, 4201 consecutive patients were prospectively enrolled in the registry. Controls comprised 2078 patients. In Group 1(n = 131 patients), DMGI exceeded 10 mmHg in 5.6%, and was not associated with greater 4-years mortality than in controls (32.6% vs. 40.1%, p = 0.27). In Group 2 (n = 144 patients), PPMG was at least 20 mmHg in 6.1% and was associated with higher 4-year mortality (48.7% versus 40.1%, p = 0.005). A total of two-thirds of the patients with PPMG ≥ 20 mmHg had MG < 20 mmHg at 1 year, with mortality similar to the controls (39.2% vs. 40.1%, p = 0.73). Patients with PPMG > 20 mmHg 1 year post-TAVI had higher 4-years mortality than the general population of the registry, unlike patients with MG normalization.
- Open Access
- 11 March 2019
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 18 (1) , 1-9
Impact of post-procedural glycemic variability on cardiovascular morbidity and mortality after transcatheter aortic valve implantation: a post hoc cohort analysis
Background: Glycemic variability is associated with worse outcomes after cardiac surgery, but the prognosis value of early glycemic variability after transcatheter aortic valve implantation is not known. This study was therefore designed to analyze the prognosis significance of post-procedural glycemic variability within 30 days after transcatheter aortic valve implantation. Methods: A post hoc analysis of patients from our center included in the FRANCE and FRANCE-2 registries was conducted. Post-procedural glycemic variability was assessed by calculating the mean daily δ blood glucose during the first 2 days after transcatheter aortic valve implantation. Major complications within 30 days were death, stroke, myocardial infarction, acute heart failure, and life-threatening cardiac arrhythmias. Results: We analyzed 160 patients (age (median [interquartile] = 84 [80–88] years; diabetes mellitus (n) = 41 (26%) patients; logistic Euroscore = 20 [12–32]). The median value of mean daily δ blood glucose was 4.3 mmol l−1. The rate of major complications within 30 days after procedure among patients with the lowest quartile of glycemic variability was 12%, increasing from 12 to 26%, and 39% in the second, third, and fourth quartiles, respectively. In multivariate analysis, glycemic variability was independently associated with an increased risk of major complications within 30 days after the procedure (odds ratio [95% CI] = 1.83 [1.19–2.83]; p = 0.006). Conclusions: This study showed that post-procedural glycemic variability was associated with an increased risk of major complications within 30 days after transcatheter aortic valve implantation. Trial registration Clinical trial registration number https://www.clinicaltrials.gov/; identifier: NCT02726958; date: April 4th, 2016
- 11 March 2019
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 18 (1) , 1-9
Open AccessImpact of post-procedural glycemic variability on cardiovascular morbidity and mortality after transcatheter aortic valve implantation: a post hoc cohort analysis
Background: Glycemic variability is associated with worse outcomes after cardiac surgery, but the prognosis value of early glycemic variability after transcatheter aortic valve implantation is not known. This study was therefore designed to analyze the prognosis significance of post-procedural glycemic variability within 30 days after transcatheter aortic valve implantation. Methods: A post hoc analysis of patients from our center included in the FRANCE and FRANCE-2 registries was conducted. Post-procedural glycemic variability was assessed by calculating the mean daily δ blood glucose during the first 2 days after transcatheter aortic valve implantation. Major complications within 30 days were death, stroke, myocardial infarction, acute heart failure, and life-threatening cardiac arrhythmias. Results: We analyzed 160 patients (age (median [interquartile] = 84 [80–88] years; diabetes mellitus (n) = 41 (26%) patients; logistic Euroscore = 20 [12–32]). The median value of mean daily δ blood glucose was 4.3 mmol l−1. The rate of major complications within 30 days after procedure among patients with the lowest quartile of glycemic variability was 12%, increasing from 12 to 26%, and 39% in the second, third, and fourth quartiles, respectively. In multivariate analysis, glycemic variability was independently associated with an increased risk of major complications within 30 days after the procedure (odds ratio [95% CI] = 1.83 [1.19–2.83]; p = 0.006). Conclusions: This study showed that post-procedural glycemic variability was associated with an increased risk of major complications within 30 days after transcatheter aortic valve implantation. Trial registration Clinical trial registration number https://www.clinicaltrials.gov/; identifier: NCT02726958; date: April 4th, 2016
- 1 July 2015
- Published by Elsevier in La Presse Médicale
- Vol. 44 (7) , 752-760
De FRANCE 2 à FRANCE TAVI : les indications, la technique et les résultats du remplacement valvulaire aortique percutané sont-ils les mêmes ?
- 1 July 2015
- Published by Elsevier in La Presse Médicale
- Vol. 44 (7) , 752-760
De FRANCE 2 à FRANCE TAVI : les indications, la technique et les résultats du remplacement valvulaire aortique percutané sont-ils les mêmes ?
- 1 February 2014
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 7 (2) , S9-S10
CRT-109 Primary Angioplasty for Acute Myocardial Infarction: What is the Results and Prognosis Factor? About a Prospective French Registry of 5000 Patients
- 1 February 2014
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 7 (2) , S9-S10
CRT-109 Primary Angioplasty for Acute Myocardial Infarction: What is the Results and Prognosis Factor? About a Prospective French Registry of 5000 Patients
- 1 April 2013
- Published by Wolters Kluwer Health in Survey of Anesthesiology
- Vol. 57 (2) , 62-63
Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients
- 1 April 2013
- Published by Wolters Kluwer Health in Survey of Anesthesiology
- Vol. 57 (2) , 62-63
Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients
- 1 January 2013
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 5 (1) , 50
151: Echocardiographic predictive factors of short-term poor outcomes after transcatheter aortic valve implantation
- 1 January 2013
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 5 (1) , 50
151: Echocardiographic predictive factors of short-term poor outcomes after transcatheter aortic valve implantation